Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
OpenUpdated: Oct 30, 2025
Summary
The purpose of this grant is to support the discovery and early evaluation of candidate biomarkers and biomarker signatures for neurological and neuromuscular disorders, facilitating the clinical development of neurotherapeutics. Eligible applicants include various government entities, nonprofit organizations, educational institutions, and small businesses, with specific provisions for certain minority-serving institutions. Application details are not provided in the description, but interested parties can contact NIH Grants Information for further inquiries.
Full Description
Description
Eligibility
Eligible applicants
Government
- City or township governments
- Public and Indian housing authorities
- Federally recognized Native American tribal governments
- Special district governments
- State governments
- County governments
Miscellaneous
- Other
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Business
- Small businesses
- For-profit organizations other than small businesses
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.